BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33619560)

  • 1. P-selectin deficiency promotes liver senescence in sickle cell disease mice.
    Vats R; Kaminski TW; Ju EM; Brozska T; Tutuncuoglu E; Tejero J; Novelli EM; Sundd P; Pradhan-Sundd T
    Blood; 2021 May; 137(19):2676-2680. PubMed ID: 33619560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired hemoglobin clearance by sinusoidal endothelium promotes vaso-occlusion and liver injury in sickle cell disease.
    Kaminski TW; Katoch O; Li Z; Hanway CB; Dubey RK; Alagbe A; Brzoska T; Zhang H; Sundd P; Kato GJ; Novelli EM; Pradhan-Sundd T
    Haematologica; 2024 May; 109(5):1535-1550. PubMed ID: 37941440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term L-Glutamine Treatment Reduces Hemolysis without Ameliorating Hepatic Vaso-Occlusion and Liver Fibrosis in a Mouse Model of Sickle Cell Disease.
    Katoch O; Ungalara R; Kaminski T; Li Z; Dubey RK; Burholt I; Gudapati S; Pradhan-Sundd T
    Biomedicines; 2023 Aug; 11(9):. PubMed ID: 37760853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver-to-lung microembolic NETs promote gasdermin D-dependent inflammatory lung injury in sickle cell disease.
    Vats R; Kaminski TW; Brzoska T; Leech JA; Tutuncuoglu E; Katoch O; Jonassaint J; Tejero J; Novelli EM; Pradhan-Sundd T; Gladwin MT; Sundd P
    Blood; 2022 Sep; 140(9):1020-1037. PubMed ID: 35737916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tandem P-selectin glycoprotein ligand immunoglobulin prevents lung vaso-occlusion in sickle cell disease mice.
    Vats R; Tutuncuoglu E; Pradhan-Sundd T; Tejero J; Shaw GD; Sundd P
    Exp Hematol; 2020 Apr; 84():1-6.e1. PubMed ID: 32243995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potent oral P-selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell disease.
    Kutlar A; Ataga KI; McMahon L; Howard J; Galacteros F; Hagar W; Vichinsky E; Cheung AT; Matsui N; Embury SH
    Am J Hematol; 2012 May; 87(5):536-9. PubMed ID: 22488107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nrf2 activation in myeloid cells and endothelial cells differentially mitigates sickle cell disease pathology in mice.
    Keleku-Lukwete N; Suzuki M; Panda H; Otsuki A; Katsuoka F; Saito R; Saigusa D; Uruno A; Yamamoto M
    Blood Adv; 2019 Apr; 3(8):1285-1297. PubMed ID: 31015205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cell adhesion by anti-P-selectin aptamer: a new potential therapeutic agent for sickle cell disease.
    Gutsaeva DR; Parkerson JB; Yerigenahally SD; Kurz JC; Schaub RG; Ikuta T; Head CA
    Blood; 2011 Jan; 117(2):727-35. PubMed ID: 20926770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEK1/2 inhibitors reverse acute vascular occlusion in mouse models of sickle cell disease.
    Zhao Y; Schwartz EA; Palmer GM; Zennadi R
    FASEB J; 2016 Mar; 30(3):1171-86. PubMed ID: 26631480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role of C5a in sickle cell disease.
    Vercellotti GM; Dalmasso AP; Schaid TR; Nguyen J; Chen C; Ericson ME; Abdulla F; Killeen T; Lindorfer MA; Taylor RP; Belcher JD
    Am J Hematol; 2019 Mar; 94(3):327-337. PubMed ID: 30569594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-selectin drives complement attack on endothelium during intravascular hemolysis in TLR-4/heme-dependent manner.
    Merle NS; Paule R; Leon J; Daugan M; Robe-Rybkine T; Poillerat V; Torset C; Frémeaux-Bacchi V; Dimitrov JD; Roumenina LT
    Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6280-6285. PubMed ID: 30850533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease.
    Belcher JD; Nguyen J; Chen C; Abdulla F; Conglin R; Ivy ZK; Cummings J; Dudler T; Vercellotti GM
    Transl Res; 2022 Nov; 249():1-12. PubMed ID: 35878790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired Bile Secretion Promotes Hepatobiliary Injury in Sickle Cell Disease.
    Vats R; Liu S; Zhu J; Mukhi D; Tutuncuoglu E; Cardenes N; Singh S; Brzoska T; Kosar K; Bamne M; Jonassaint J; Adebayo Michael A; Watkins SC; Hillery C; Ma X; Nejak-Bowen K; Rojas M; Gladwin MT; Kato GJ; Ramakrishnan S; Sundd P; Monga SP; Pradhan-Sundd T
    Hepatology; 2020 Dec; 72(6):2165-2181. PubMed ID: 32190913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary supplementation with sulforaphane attenuates liver damage and heme overload in a sickle cell disease murine model.
    Panda H; Keleku-Lukwete N; Kuga A; Fuke N; Suganuma H; Suzuki M; Yamamoto M
    Exp Hematol; 2019 Sep; 77():51-60.e1. PubMed ID: 31404577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-selectin-deficient mice to study pathophysiology of sickle cell disease.
    Bennewitz MF; Tutuncuoglu E; Gudapati S; Brzoska T; Watkins SC; Monga SP; Pradhan-Sundd T; Sundd P
    Blood Adv; 2020 Jan; 4(2):266-273. PubMed ID: 31968076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuregulin-1 attenuates hemolysis- and ischemia induced-cerebrovascular inflammation associated with sickle cell disease.
    Chambliss C; Stiles JK; Gee BE
    J Stroke Cerebrovasc Dis; 2023 Feb; 32(2):106912. PubMed ID: 36473396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonistic Anti-CD40 Antibody Triggers an Acute Liver Crisis With Systemic Inflammation in Humanized Sickle Cell Disease Mice.
    Yalamanoglu A; Dubach IL; Schulthess N; Ingoglia G; Swindle DC; Humar R; Schaer DJ; Buehler PW; Irwin DC; Vallelian F
    Front Immunol; 2021; 12():627944. PubMed ID: 33763072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-hematopoietic deficiency of proprotein convertase subtilisin/kexin type 9 deficiency leads to more severe anemia in a murine model of sickle cell disease.
    Venugopal J; Wang J; Guo C; Lu H; Chen YE; Eitzman DT
    Sci Rep; 2020 Oct; 10(1):16514. PubMed ID: 33020528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet Extracellular Vesicles Drive Inflammasome-IL-1β-Dependent Lung Injury in Sickle Cell Disease.
    Vats R; Brzoska T; Bennewitz MF; Jimenez MA; Pradhan-Sundd T; Tutuncuoglu E; Jonassaint J; Gutierrez E; Watkins SC; Shiva S; Scott MJ; Morelli AE; Neal MD; Kato GJ; Gladwin MT; Sundd P
    Am J Respir Crit Care Med; 2020 Jan; 201(1):33-46. PubMed ID: 31498653
    [No Abstract]   [Full Text] [Related]  

  • 20. Cellular adhesion and the endothelium: P-selectin.
    Kutlar A; Embury SH
    Hematol Oncol Clin North Am; 2014 Apr; 28(2):323-39. PubMed ID: 24589269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.